Quince Therapeutics Inc [NASDAQ: QNCX] surged by $0.32 during the normal trading session on while it closed the day at $1.19.
Quince Therapeutics Inc stock has also gained 50.08% of its value over the past 7 days. However, QNCX stock has inclined by 51.46% in the 3 months of the year. Over the past six months meanwhile, it has gained 15.53% and gained 13.33% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for QNCX stock reached $51.50 million, with 42.97 million shares outstanding and 32.08 million shares in the current float. Compared to the average trading volume of 162.61K shares, QNCX reached a trading volume of 6863789 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Quince Therapeutics Inc [QNCX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QNCX shares is $12.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QNCX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Quince Therapeutics Inc is set at 0.09 The Price to Book ratio for the last quarter was 1.10, with the Price to Cash per share for the same quarter was set at 1.37.
QNCX stock trade performance evaluation
Quince Therapeutics Inc [QNCX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 50.08. With this latest performance, QNCX shares gained by 48.94% in over the last four-week period, additionally plugging by 15.53% over the last 6 months – not to mention a rise of 19.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for QNCX stock in for the last two-week period is set at 80.96, with the RSI for the last a single of trading hit 86.99, and the three-weeks RSI is set at 76.22 for Quince Therapeutics Inc [QNCX]. The present Moving Average for the last 50 days of trading for this stock 0.7396, while it was recorded at 0.9043 for the last single week of trading, and 0.9310 for the last 200 days.
Quince Therapeutics Inc [QNCX]: An insightful look at the core fundamentals
Quince Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.15 and a Current Ratio set at 6.15.
Earnings per share (EPS) analysis for Quince Therapeutics Inc [QNCX] stock
With the latest financial reports released by the company, Quince Therapeutics Inc posted -0.72/share EPS, while the average EPS was predicted by analysts to be reported at -0.55/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.17. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for QNCX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Quince Therapeutics Inc go to 18.30%.
Quince Therapeutics Inc [QNCX]: Institutional Ownership
There are presently around $25.24%, or 29.27%% of QNCX stock, in the hands of institutional investors.
